Tibet AIM Pharm. Inc.
SZSE:002826.SZ
10.97 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 385.856 | 321.283 | 182.725 | 205.322 | 159.913 | 238.707 | 261.616 | 281.322 | 38.147 | 39.128 | 26.525 |
| Short Term Investments
| -0 | 0 | 0 | 0 | 30 | 0 | 0 | 0 | -0.571 | 2.2 | 0 |
| Cash and Short Term Investments
| 385.856 | 321.283 | 182.725 | 205.322 | 189.913 | 238.707 | 261.616 | 281.322 | 38.147 | 39.128 | 26.525 |
| Net Receivables
| 44.634 | 208.06 | 141.855 | 223.945 | 173.44 | 195.447 | 182.606 | 133.42 | 123.002 | 87.469 | 23.285 |
| Inventory
| 58.969 | 45.554 | 33.608 | 20.699 | 29.601 | 28.662 | 34.17 | 36.677 | 46.538 | 30.154 | 27.742 |
| Other Current Assets
| 0.212 | 0.113 | 3.985 | 0.286 | 7.615 | 1.401 | 1.17 | 0.592 | 0.708 | 2.972 | 0.585 |
| Total Current Assets
| 489.67 | 575.009 | 362.174 | 450.253 | 400.568 | 464.217 | 479.561 | 452.01 | 208.395 | 159.723 | 78.136 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 349.154 | 364.848 | 378.961 | 396.146 | 368.147 | 198.392 | 177.359 | 139.813 | 135.404 | 45.373 | 26.24 |
| Goodwill
| 16.669 | 36.473 | 36.473 | 7.667 | 7.667 | 7.667 | 7.667 | 7.667 | 7.667 | 7.667 | 7.667 |
| Intangible Assets
| 25.907 | 31.102 | 37.248 | 43.61 | 46.947 | 46.192 | 42.97 | 39.126 | 38.246 | 23.161 | 15.01 |
| Goodwill and Intangible Assets
| 42.576 | 67.575 | 73.721 | 51.277 | 54.614 | 53.859 | 50.637 | 46.793 | 45.914 | 30.828 | 22.677 |
| Long Term Investments
| 42.567 | 0 | 3.569 | 0 | 0 | 0 | 0.112 | 0.273 | 0.711 | 0.521 | 0.278 |
| Tax Assets
| 3.512 | 4.81 | 2.128 | 5.681 | 2.038 | 3.225 | 4.365 | 6.29 | 6.938 | 3.9 | 8.764 |
| Other Non-Current Assets
| 0.263 | 5.962 | 3.922 | 4.731 | 10.04 | 38.242 | 21.256 | 1.181 | 0.335 | 28.073 | 17.003 |
| Total Non-Current Assets
| 438.073 | 443.195 | 462.3 | 457.835 | 434.838 | 293.717 | 253.73 | 194.35 | 189.301 | 108.695 | 74.961 |
| Total Assets
| 927.744 | 1,018.205 | 824.473 | 908.087 | 835.406 | 757.934 | 733.291 | 646.361 | 397.696 | 268.418 | 153.097 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 106.043 | 127.013 | 17.201 | 39.196 | 26.964 | 11.225 | 8.147 | 14.3 | 19.272 | 5.397 | 3.721 |
| Short Term Debt
| 11.011 | 50.051 | 6.648 | 40 | 70 | 40 | -48.128 | 10 | 20 | 10 | 20 |
| Tax Payables
| 5.217 | 15.622 | 8.989 | 19.442 | 9.266 | 10.406 | 13.356 | 5.182 | 12.533 | 3.812 | 7.602 |
| Deferred Revenue
| 53.57 | 4.206 | 9.236 | 132.972 | 78.088 | 10.406 | 48.128 | 43.377 | 36.475 | 27.147 | 36.931 |
| Other Current Liabilities
| 0.456 | 80.644 | 66.262 | 6.103 | 5.252 | 76.031 | 117.992 | 21.218 | 31.748 | 46.503 | 20.781 |
| Total Current Liabilities
| 171.08 | 261.914 | 99.347 | 218.271 | 180.305 | 137.661 | 126.14 | 88.895 | 107.495 | 89.046 | 81.433 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0.169 | 0 | 0 | 0 | 0 | 40 | 0 | 0 |
| Deferred Revenue Non-Current
| 6.604 | 4.432 | 5.016 | 2.67 | 2.932 | 1.872 | 2.123 | 1.53 | 1.7 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -2.839 | 0 | 0 | 0 | 0 | -39.75 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 1.862 | 0 | 2.67 | 0 | 0 | 0.5 | 0.5 | 40 | 0.25 | 0 |
| Total Non-Current Liabilities
| 6.604 | 6.294 | 5.016 | 2.67 | 2.932 | 1.872 | 2.623 | 2.03 | 41.95 | 0.25 | 0 |
| Total Liabilities
| 177.684 | 268.208 | 104.363 | 220.941 | 183.237 | 139.533 | 128.762 | 90.925 | 149.445 | 89.296 | 81.433 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 190.678 | 190.682 | 191.19 | 191.769 | 193.21 | 189.72 | 189.72 | 189.72 | 142.29 | 135 | 50 |
| Retained Earnings
| 297.421 | 301.101 | 276.346 | 249.773 | 216.817 | 186.992 | 174.072 | 130.131 | 80.002 | 34.176 | 14.231 |
| Accumulated Other Comprehensive Income/Loss
| 3.397 | 20.83 | 17.271 | 12.889 | 3.374 | 17.579 | 16.627 | 11.475 | 25.959 | 0 | 0 |
| Other Total Stockholders Equity
| 253.522 | 232.68 | 232.582 | 232.715 | 238.767 | 224.109 | 224.109 | 224.109 | 0 | 9.946 | 0.799 |
| Total Shareholders Equity
| 745.018 | 745.294 | 717.39 | 687.146 | 652.169 | 618.401 | 604.529 | 555.436 | 248.251 | 179.122 | 65.03 |
| Total Equity
| 750.059 | 749.996 | 720.111 | 687.146 | 652.169 | 618.401 | 604.529 | 555.436 | 248.251 | 179.122 | 71.665 |
| Total Liabilities & Shareholders Equity
| 927.744 | 1,018.205 | 824.473 | 908.087 | 835.406 | 757.934 | 733.291 | 646.361 | 397.696 | 268.418 | 153.097 |